These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8271380)

  • 1. [Sulfated curdlan and sulfated alkyl oligosaccharide as anti-viral agent].
    Uryu T
    Nihon Rinsho; 1993 Sep; 51 Suppl():164-8. PubMed ID: 8271380
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2.
    Yoshida T; Yasuda Y; Mimura T; Kaneko Y; Nakashima H; Yamamoto N; Uryu T
    Carbohydr Res; 1995 Oct; 276(2):425-36. PubMed ID: 8542610
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection.
    Uryu T; Ikushima N; Katsuraya K; Shoji T; Takahashi N; Yoshida T; Kanno K; Murakami T; Nakashima H; Yamamoto N
    Biochem Pharmacol; 1992 Jun; 43(11):2385-92. PubMed ID: 1351727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of sulfated alkyl malto- and laminara-oligosaccharides with potent inhibitory effects on AIDS virus infection.
    Katsuraya K; Ikushima N; Takahashi N; Shoji T; Nakashima H; Yamamoto N; Yoshida T; Uryu T
    Carbohydr Res; 1994 Jul; 260(1):51-61. PubMed ID: 8062289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curdlan sulfate and HIV-1: II. In vitro long-term treatment of HIV-1 infection with curdlan sulfate.
    Aoki T; Kaneko Y; Nguyen T; Stefanski MS; Ting RC; Manak MM
    AIDS Res Hum Retroviruses; 1992 May; 8(5):605-12. PubMed ID: 1515213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of curdlan sulfate in the production of beta-chemokines and interleukin-16.
    Naito T; Takeda-Hirokawa N; Kaneko H; Sekigawa I; Matsumoto T; Hashimoto H; Kaneko Y
    Med Microbiol Immunol; 1998 Jun; 187(1):43-8. PubMed ID: 9749981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes.
    Gordon M; Guralnik M; Kaneko Y; Mimura T; Baker M; Lang W
    J Med; 1994; 25(3-4):163-80. PubMed ID: 7996061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro.
    Kaneko Y; Yoshida O; Nakagawa R; Yoshida T; Date M; Ogihara S; Shioya S; Matsuzawa Y; Nagashima N; Irie Y
    Biochem Pharmacol; 1990 Feb; 39(4):793-7. PubMed ID: 1968342
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sulfated schizophyllan as a anti-HIV agent].
    Sugawara I; Hirata A; Itoh W
    Nihon Rinsho; 1993 Sep; 51 Suppl():158-63. PubMed ID: 7505844
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of sulfated fungal beta-glucans from the sclerotium of Pleurotus tuber-regium as a potential water-soluble anti-viral agent.
    Zhang M; Cheung PC; Ooi VE; Zhang L
    Carbohydr Res; 2004 Sep; 339(13):2297-301. PubMed ID: 15337458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of curdlan sulfate on the production of beta-chemokines and cytokines.
    Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Hashimoto H; Sekigawa I; Hirose S; Yamanoto N; Kaneko Y
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):723-5. PubMed ID: 9643371
    [No Abstract]   [Full Text] [Related]  

  • 13. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
    Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
    J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of high-molecular-weight-(1-->3)-beta-D-glucan-dependent activation of a limulus coagulation factor G by laminaran oligosaccharides and curdlan degradation products.
    Tanaka S; Aketagawa J; Takahashi S; Shibata Y; Tsumuraya Y; Hashimoto Y
    Carbohydr Res; 1993 May; 244(1):115-27. PubMed ID: 8339297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and biological activities of sulfated derivatives of (1----3)-beta-D-glucans.
    Suzuki T; Ohno N; Adachi Y; Cirelli AF; Covian JA; Yadomae T
    J Pharmacobiodyn; 1991 May; 14(5):256-66. PubMed ID: 1770430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of Achyranthes bidentata polysaccharide sulfate and its antivirus activity].
    Tian GY; Li ST; Song ML; Zheng MS; Li W
    Yao Xue Xue Bao; 1995; 30(2):107-11. PubMed ID: 7785433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.
    Jagodzinski PP; Wiaderkiewicz R; Kurzawski G; Kloczewiak M; Nakashima H; Hyjek E; Yamamoto N; Uryu T; Kaneko Y; Posner MR
    Virology; 1994 Aug; 202(2):735-45. PubMed ID: 7913276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1.
    Said J; Trybala E; Andersson E; Johnstone K; Liu L; Wimmer N; Ferro V; Bergström T
    Antiviral Res; 2010 Jun; 86(3):286-95. PubMed ID: 20307578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further clinical studies of curdlan sulfate (CRDS)--an anti-HIV agent.
    Gordon M; Guralnik M; Kaneko Y; Mimura T; Goodgame J; Lang W
    J Med; 1995; 26(3-4):97-131. PubMed ID: 8558101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus.
    Ekblad M; Adamiak B; Bergstrom T; Johnstone KD; Karoli T; Liu L; Ferro V; Trybala E
    Antiviral Res; 2010 May; 86(2):196-203. PubMed ID: 20176055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.